Interní Med. 2008; 10(4): 179-183

The more common recurrent clinical manifestations of Herpesvirus Infection in Man, prevention and therapy

doc. MUDr. Drahomíra Bartošová CSc
Klinika dětských infekčních nemocí FN a LF MU, Brno

Herpesviruses which affect man occur ubiquitously in all populations throughout the world. It is a characteristic feature of herpesvirus that they generally remain in a latent form after clearance of the primary infection. The overall majority of clinical problems are related to activated latent infections, eg., recurrent lesions of herpes simplex labialis or herpes genitalis and in particular herpesvirus infections and reactivation in immunodeficient individuals. The review concerns the more common recurrent clinical manifestations of herpesvirus simplex infection (HSV 1, 2) in man and a new approaches to the prevention and therapy.

Keywords: herpes simplex virus type 1 and 2, herpes genitalis, herpes labialis, short-course therapy, episodic therapy, suppressive therapy, immunomodulation, vaccination, prevention

Published: May 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bartošová D. The more common recurrent clinical manifestations of Herpesvirus Infection in Man, prevention and therapy. Interní Med. 2008;10(4):179-183.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bartošová D, Klapačová L, Hálová J. Klinická manifestace herpesvirových onemocnění. Čs Pediat 1997; 9: 700-703.
    2. Bartošová D, Klapačová L. Suprese recidivujících infekcí vyvolaných virem herpes simplex u dětí. Čs Pediat., 2000; 8 (55): 488-491.
    3. Corey L. Herpes Simplex Virus. In: Mandell, Douglas and Bennett´s principles and practice of infectious diseases, 5. vyd. Philadelphia, Churchill Livingstone, 2000: 1564-1575.
    4. Corey L, Stanberry L. Recommendations for short-course therapies in herpes genitalis and herpes labialis, Herpes, IHMF, 2007 (14) 1.
    5. Enright A M, Prober Ch. Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections. Herpes 2003; 2: 32-38.
    6. Forsgren M, Malm C. Herpes simplex. In: Newell ML, McIntyre J. Congenital and perinatal infections. Cambridge University Press, 2000: 145-163. Go to original source...
    7. Klapačová L, Bartošová D, Stomatitis aphtosa - léčba acyklovirem. Scripta Medica 1996; 3-4: 141-160.
    8. Kusuhara T, Nakajima H, Takahashi M, Yamada T. Parainfectious encephalomyeloradiculitis associated with herpes simplex virus 1 DNA in cerebrospinal fluid. Clinical Infectious Diseases 2002; 34: 1199-1205. Go to original source... Go to PubMed...
    9. Leone PA, Trottier S, Miller JM. Valacyclovir for episodic treatment of genital herpes: A shorter 3-day treatment course compared with 5-day treatment. Clinical Infectious Diseases 2002; 34: 958-962. Go to original source... Go to PubMed...
    10. Rabella N, Otequi M, Labeaga R, et al. Antiviral susceptibility of herpes simplex viruses and its clinical correlates: A single center's experience. Clinical Infectious Diseases 2002; 34: 1055-1060. Go to original source... Go to PubMed...
    11. Wald A, Carell D, Remington M, et al. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection. Clinical Infectious Diseases 2002; 34: 944-948. Go to original source... Go to PubMed...
    12. Weil AA, Glase A, Amad Z, Forghani B. Patients with suspected herpes simplex encephalitis: Rethinking an initial negative polymerase chain reaction result. Clinical Infectious Diseases 2002; 34: 1154-1157. Go to original source... Go to PubMed...
    13. Zicha J. Herpes genitalis sexuálně přenosná choroba, Mediforum 2000, 1. vydání.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.